Jieyu Chufan capsules | China Drugs List

Public reference information, not medical advice, a prescription or an offer to supply a medicine. Confirm current approval, availability and suitability with licensed professionals.

Medicine type
Traditional Chinese medicine
Therapeutic area
Mental health & sleep
Indications recorded in the public source
In TCM, relieves constraint and resolves phlegm, clears heat and eases restlessness. For mild-to-moderate depression with qi stagnation and phlegm obstruction and internal disturbance by constrained fire. Manifestations include low mood, restlessness, a sensation of a foreign body in the throat, chest or epigastric fullness, poor appetite, frequent sighing, insomnia and excessive dreaming, dizziness and tinnitus, a bitter taste and dry throat, constipation, and a red tongue with a greasy coating and a wiry-slippery pulse.
Indication source and scope
Source date(s): 2024. Indications transcribed from the public NHSA manufacturer submission; this is not verification of the complete current label. Additional indications may be supported by newer announcements or submissions rather than the older full label; see the indication sources.
Prescribing-information limitations
Indications checked against an official public submission. The full original prescribing information is still unavailable.
China availability status
Historical Chinese approval verified; current continuous market availability has not been checked for every product.
Overseas status
Market-by-market verification pending.
Insurance classification
Included in national insurance (Category B)
Insurance edition
2025 edition; effective 1 January 2026
Insurance restrictions
No additional restriction is specified for this NRDL entry; the general NRDL rules and legally approved indications still apply.
Insurance period
2025-01-01 to 2026-12-31
Insurance verification notes
Matched by exact or normalized ingredient/formulation name. Reimbursement still depends on the dosage form and listed payment restrictions.

Sources

Open the interactive record, public price references and discussions